AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 14%
#4243 out of 4870 analysts
Average Return
-2.16%
Win Rate
27%24 out of 89
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+305.95%$8.07$32.76
2024-06-25 -
2025-05-01
Buy
Scholar Rock Holding CorpSRRK
+234.29%$9.80$32.76
2024-06-04 -
2025-05-01
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+203.61%$10.79$32.76
2024-05-23 -
2025-05-01
Buy
Werewolf Therapeutics IncHOWL
+180.18%$2.17$6.08
2023-03-23 -
2024-03-22
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Erasca IncERAS
10Buy$6.00+302.68%Reiterates
3 days ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+212.50%Reiterates
3 days ago
Sutro Biopharma IncSTRO
1Hold$2.00+86.92%Reiterates
4 days ago
Protara Therapeutics IncTARA
1Buy$23.00+564.74%Reiterates
5 days ago
Cg Oncology IncCGON
13Buy$75.00+170.37%Reiterates
5 days ago
Immunitybio IncIBRX
2Buy$8.00+221.29%Reiterates
17 days ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+372.44%Reiterates
a month ago
Mural Oncology PLCMURA
5Buy$6.00+129.89%Maintains
a month ago
Corbus Pharmaceuticals Holdings IncCRBP
1Buy$50.00+564.89%Reiterates
2 months ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+1,622.16%Reiterates
2 months ago
Engene Holdings IncENGN
2Buy$25.00+568.45%Reiterates
2 months ago
Scholar Rock Holding CorpSRRK
13Buy$50.00+52.63%Maintains
5 months ago
Ikena Oncology IncIKNA
11Buy$4.00+227.87%Reiterates
6 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.